The emerging utility of the cutaneous microbiome in the treatment of acne and atopic dermatitis
- PMID: 31499149
- DOI: 10.1016/j.jaad.2019.08.078
The emerging utility of the cutaneous microbiome in the treatment of acne and atopic dermatitis
Abstract
The cutaneous microbiome has potential for therapeutic intervention in inflammatory-driven skin disease. Research into atopic dermatitis and acne vulgaris has highlighted the importance of the skin microbiota in disease pathogenesis, prognostication, and targets for therapeutic intervention. Current management of these conditions aims to control the inflammatory response thought to be associated with specific pathogens using both topical and systemic antimicrobials. However, commensal microbiota found naturally on the skin have been shown to play an important role in the resolution of disease flares. Although often efficacious, the mainstay treatments are not without adverse effects and raise concerns regarding the development of antimicrobial resistance. Augmentation of microbial communities with targeted biotherapy could revolutionize the way inflammatory conditions of the skin are treated. Herein, we review evidence for the role of the cutaneous microbiome in atopic dermatitis and acne vulgaris and suggest that these conditions highlight the potential for microbiome-directed therapeutics.
Keywords: acne vulgaris; atopic dermatitis; biotherapy; microbiome.
Copyright © 2019 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.
Similar articles
-
An approach on the potential use of probiotics in the treatment of skin conditions: acne and atopic dermatitis.Int J Dermatol. 2018 Dec;57(12):1425-1432. doi: 10.1111/ijd.13972. Epub 2018 Apr 20. Int J Dermatol. 2018. PMID: 29676446 Review.
-
The skin microbiome: Associations between altered microbial communities and disease.Australas J Dermatol. 2015 Nov;56(4):268-74. doi: 10.1111/ajd.12253. Epub 2015 Feb 25. Australas J Dermatol. 2015. PMID: 25715969 Review.
-
[The skin microbiota: a colossus steps into the spotlight].Rev Med Suisse. 2016 Mar 30;12(512):660-4. Rev Med Suisse. 2016. PMID: 27172697 Review. French.
-
Targeting dysbiosis in psoriasis, atopic dermatitis, and hidradenitis suppurativa: the gut-skin axis and microbiome-directed therapy.Clin Dermatol. 2023 Sep-Oct;41(5):640-649. doi: 10.1016/j.clindermatol.2023.09.019. Epub 2023 Oct 9. Clin Dermatol. 2023. PMID: 37816413 Review.
-
The microbiome in dermatology.Clin Dermatol. 2018 May-Jun;36(3):390-398. doi: 10.1016/j.clindermatol.2018.03.012. Epub 2018 Mar 10. Clin Dermatol. 2018. PMID: 29908581
Cited by
-
Microbial Dysbiosis in the Skin Microbiome and Its Psychological Consequences.Microorganisms. 2024 Sep 19;12(9):1908. doi: 10.3390/microorganisms12091908. Microorganisms. 2024. PMID: 39338582 Free PMC article. Review.
-
The updates and implications of cutaneous microbiota in acne.Cell Biosci. 2023 Jun 21;13(1):113. doi: 10.1186/s13578-023-01072-w. Cell Biosci. 2023. PMID: 37344849 Free PMC article. Review.
-
Antimicrobial Activity of Gelatin Nanofibers Enriched by Essential Oils against Cutibacterium acnes and Staphylococcus epidermidis.Nanomaterials (Basel). 2023 Feb 24;13(5):844. doi: 10.3390/nano13050844. Nanomaterials (Basel). 2023. PMID: 36903722 Free PMC article.
-
Targeting Interleukin 13 for the Treatment of Atopic Dermatitis.Pharmaceutics. 2023 Feb 8;15(2):568. doi: 10.3390/pharmaceutics15020568. Pharmaceutics. 2023. PMID: 36839890 Free PMC article. Review.
-
Staphylococcus epidermidis and its dual lifestyle in skin health and infection.Nat Rev Microbiol. 2023 Feb;21(2):97-111. doi: 10.1038/s41579-022-00780-3. Epub 2022 Aug 30. Nat Rev Microbiol. 2023. PMID: 36042296 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
